|
US20020072509A1
(en)
*
|
2000-10-11 |
2002-06-13 |
Stein Donald Gerald |
Methods for the treatment of a traumatic central nervous system injury
|
|
SE0104423D0
(sv)
*
|
2001-12-27 |
2001-12-27 |
Umecrine Ab |
Pregnane steroids and their use in the treatment of CNS disorders
|
|
CN101076340B
(zh)
*
|
2004-11-18 |
2011-01-12 |
梅克芳股份公司 |
Gaba-类固醇拮抗剂及其治疗cns障碍的用途
|
|
RU2413516C2
(ru)
*
|
2004-11-18 |
2011-03-10 |
Умекрин Аб |
Гамк-стероидные антагонисты и их применение в лечении нарушений цнс
|
|
DE102006003508A1
(de)
*
|
2006-01-24 |
2007-07-26 |
Grünenthal GmbH |
Arzneimittel umfassend eine Hormonkombination
|
|
DE102006003509A1
(de)
*
|
2006-01-24 |
2007-07-26 |
Grünenthal GmbH |
Kontrazeptivum
|
|
US20070203216A1
(en)
*
|
2006-02-14 |
2007-08-30 |
Bjarke Ebert |
Method of treating inflammatory diseases
|
|
DK2792681T3
(en)
|
2006-11-21 |
2017-01-23 |
Umecrine Ab |
Use of Pregnancy and Androstan Steroids in the Preparation of a Pharmaceutical Composition for the Treatment of CNS Disorders.
|
|
US20100204192A1
(en)
|
2007-06-11 |
2010-08-12 |
University Of Sourthern California |
Agents, compositions and methods for enhancing neurological function
|
|
EP2167098B1
(en)
*
|
2007-06-11 |
2018-09-05 |
University Of Southern California |
Allopregnanolone in a method for enhancing neurological function (alzheimer disease)
|
|
US20090048288A1
(en)
*
|
2007-08-13 |
2009-02-19 |
H. Lundbeck A/S |
Method of treating stress-mediated depression
|
|
RU2012133627A
(ru)
*
|
2010-01-14 |
2014-04-20 |
Умекрине Муд Аб |
Фармацевтическая композиция, содержащая 3-бета-гидрокси-5-альфа-прегнан-20-он, с улучшенными свойствами хранения и растворимости
|
|
PL2709631T3
(pl)
|
2011-05-20 |
2017-07-31 |
Inserm - Institut National De La Santé Et De La Recherche Médicale |
Antagoniści receptora cb1
|
|
WO2013043985A1
(en)
|
2011-09-23 |
2013-03-28 |
The Regents Of The University Of California |
Edible oils to enhance delivery of orally administered steroids
|
|
EP2806877B2
(en)
*
|
2012-01-23 |
2025-01-29 |
Sage Therapeutics, Inc. |
Neuroactive steroid formulations comprising a complex of allopregnanolone and sulfobutyl ether beta-cyclodextrin
|
|
US20140050789A1
(en)
|
2012-08-13 |
2014-02-20 |
The Regents Of The University Of California |
Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
|
|
CA2882708A1
(en)
|
2012-08-21 |
2014-02-27 |
Sage Therapeutics, Inc. |
Methods of treating epilepsy or status epilepticus
|
|
ES2621528T3
(es)
|
2012-11-28 |
2017-07-04 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Derivados de 3-(4-sustituido)-bencil éter de pregnenolona
|
|
AU2013352141B2
(en)
*
|
2012-11-30 |
2018-04-05 |
The Regents Of The University Of California |
Anticonvulsant activity of steroids
|
|
RU2684616C2
(ru)
|
2014-01-29 |
2019-04-10 |
Умекрин Когнишн Аб |
Стероидное соединение для применения в лечении печеночной энцефалопатии
|
|
JOP20200195A1
(ar)
|
2014-09-08 |
2017-06-16 |
Sage Therapeutics Inc |
سترويدات وتركيبات نشطة عصبياً، واستخداماتها
|
|
WO2016082789A1
(en)
*
|
2014-11-27 |
2016-06-02 |
Sage Therapeutics, Inc. |
Compositions and methods for treating cns disorders
|
|
AR103384A1
(es)
|
2015-01-12 |
2017-05-03 |
Umecrine Cognition Ab |
3a-ETINILO, 3b-HIDROXI, 5a-PREGNAN-20-OXIMA COMO MODULADOR DE GABA
|
|
KR20240157128A
(ko)
|
2016-03-08 |
2024-10-31 |
세이지 테라퓨틱스, 인크. |
신경활성 스테로이드, 조성물, 및 그의 용도
|
|
US10278977B2
(en)
|
2016-06-06 |
2019-05-07 |
Umecrine Cognition Ab |
Methods for treating hypersomnolence
|
|
RS67063B1
(sr)
*
|
2017-01-09 |
2025-08-29 |
Relmada Therapeutics Inc |
Injektabilne suspenzije
|
|
WO2018147792A1
(en)
*
|
2017-02-10 |
2018-08-16 |
Asarina Pharma Ab |
3-beta-hydroxy-5-alpha-pregnan-20-one for use in medical treatment
|
|
WO2018147791A1
(en)
*
|
2017-02-10 |
2018-08-16 |
Asarina Pharma Ab |
3-beta-hydroxy-5-alpha-pregnan-20-one for use in treatment of essential tremor
|
|
US20210228596A1
(en)
*
|
2017-10-12 |
2021-07-29 |
Sage Therapeutics, Inc. |
Method of treating cns disorders with neurosteroids and gabaergic compounds
|
|
JP2021519799A
(ja)
|
2018-04-05 |
2021-08-12 |
アサリナ ファーマ エーピーエス |
物質離脱障害を治療するためのｇａｂａ−ａアンタゴニスト
|
|
KR20240050372A
(ko)
|
2021-09-14 |
2024-04-18 |
난징 미노바 파마슈티컬 컴퍼니, 리미티드 |
수용성 알로프레그나놀론 유도체 및 이의 제조 방법과 용도
|
|
US20250387409A1
(en)
|
2021-11-10 |
2025-12-25 |
Umecrine Cognition Ab |
3-beta-hydroxy-3-alpha-ethyl steroids for modulation of the alpha-3 subtype of the gabaa receptor
|
|
CA3237550A1
(en)
|
2021-11-10 |
2023-05-19 |
Umecrine Ab |
3.alpha.-substituted 3.beta.-hydroxy 17-oximated androstane compound for modulation of the alpha-3 subtype of the gaba-a receptor
|
|
WO2023083980A1
(en)
|
2021-11-10 |
2023-05-19 |
Umecrine Ab |
Steroid as a modulator of gabaa receptor
|